CMA vs ORMP
CMA (CMA) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
CMA (CMA) common stock.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
CMA does not have a complete income-statement cache yet.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
ORMP currently screens at market cap $87.2M.
Not investment advice. Open the CMA and ORMP stock pages for the full models.
Not investment advice.